EP 1143990 A3 20020327 - PHARMACEUTICAL COMPOSTIONS COMPRISING PEG-ASPARAGINASE FOR THE TREATMENT OF HIV INFECTIONS
Title (en)
PHARMACEUTICAL COMPOSTIONS COMPRISING PEG-ASPARAGINASE FOR THE TREATMENT OF HIV INFECTIONS
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG, ENTHALTEND PEG-ASPARAGINASE, FÜR DIE BEHANDLUNG VON HIV INFEKTIONEN
Title (fr)
COMPOSITION ET PROCEDES DE TRAITEMENT D'INFECTION PAR LE VIH
Publication
Application
Priority
- US 0021462 W 20000807
- US 37039099 A 19990806
Abstract (en)
[origin: WO0110454A2] Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection, comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound or asparaginase, and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.
IPC 1-7
IPC 8 full level
C12N 9/99 (2006.01); A61K 38/45 (2006.01); A61K 38/50 (2006.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); A61P 31/18 (2006.01)
CPC (source: EP)
A61K 38/50 (2013.01); A61P 31/18 (2017.12)
Citation (search report)
See references of WO 0110454A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL
DOCDB simple family (publication)
WO 0110454 A2 20010215; WO 0110454 A3 20020124; WO 0110454 A9 20021107; WO 0110454 B1 20020711; AU 6894400 A 20010305; CA 2346063 A1 20010215; EP 1143990 A2 20011017; EP 1143990 A3 20020327; HK 1041444 A1 20020712; JP 2003506409 A 20030218; ZA 200102506 B 20020327
DOCDB simple family (application)
US 0021462 W 20000807; AU 6894400 A 20000807; CA 2346063 A 20000807; EP 00957306 A 20000807; HK 02102802 A 20020413; JP 2001514970 A 20000807; ZA 200102506 A 20000807